New Trends in Vaccines Development

Vaccine development remains challenging because of the highly sophisticated evasion mechanisms of pathogens for which vaccines are not yet available. Recent years have witnessed both successes and failures of novel vaccine design and the strength of iterative approaches is increasingly appreciated. These combine the discovery of novel antigens, adjuvants, and vectors in the preclinical stage with computational analyses of clinical data to accelerate vaccine design. Reverse and structural vaccinology have revealed novel antigen candidates and molecular immunology has led to the formulation of promising adjuvants. Gene expression profiles and immune parameters in patients, vaccines, and healthy controls have formed the basis for bio-signatures that will provide guidelines for future vaccine design.

  • Antigen discovery
  • Immunological challenges
  • Aspects of pathology and host responses
  • Expanded testing and modelling of vaccine
  • Chloroplast-derived vaccines antigens and therapeutics

Related Conference of New Trends in Vaccines Development

October 18-19, 2023

43rd Global Summit and Expo on Vaccines & Immunology

Vienna, Austria
November 04-05, 2023

35th Annual Congress on Vaccine and Clinical Trials

Toronto, Canada
November 06-07, 2023

5th World Congress on Vaccine and Immunology

Tokyo, Japan
February 08-09, 2024

4th International Conference on Vaccine Research

Madrid, Spain
May 30-31, 2024

Virology Congress

Vienna, Austria

New Trends in Vaccines Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in